dr. moore on early-phase data with mirvetuximab soravtansine in ovarian cancer
Published 4 years ago • 276 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
2:28
dr. moore on the role of mirvetuximab soravtansine in ovarian cancer
-
1:49
dr. moore on safety profile of mirvetuximab soravtansine in ovarian cancer
-
1:41
dr. moore on benefit of mirvetuximab soravtansine in patients with ovarian cancer
-
2:19
dr. moore on anticipated impact of the mirasol trial in platinum-resistant ovarian cancer
-
1:47
mirvetuximab soravtansine remains well tolerated in platinum-resistant ovarian cancer
-
0:54
dr. moore on the prevalence of ovarian cancer
-
1:15
dr. o’malley on the safety profile of mirvetuximab in ovarian cancer
-
4:46
#esmo19: forward i (gog 3011) study for platinum-resistant ovarian cancer
-
0:59
dr secord on mirvetuximab soravtansine in platinum-sensitive, frα-high ovarian cancer
-
1:34
dr. moore on challenges with immunotherapy in ovarian cancer
-
2:09
dr. moore on the nova trial for ovarian cancer
-
0:58
dr. o’malley on the utility of mirvetuximab in ovarian cancer
-
2:43
dr. moore on the impact of solo-1 in ovarian cancer
-
1:50
an overview of a study exploring mirvetuximab soravtansine in ovarian cancer
-
1:16
dr. moore discusses combinations in ovarian cancer
-
1:13
dr. o’malley on the activity of mirvetuximab soravtansine in ovarian cancer
-
1:59
dr. english on mirvetuximab soravtansine in ovarian cancer
-
1:27
dr. gilbert on evaluating mirvetuximab soravtansine in platinum-agnostic ovarian cancer
-
2:20
dr. moore on the results of the nova trial in ovarian cancer